114
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation

, , , , , ORCID Icon, & show all
Pages 3451-3461 | Published online: 10 Aug 2021

References

  • SiegelRL, MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
  • WaksAG, WinerEP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300. doi:10.1001/jama.2018.1932330667505
  • ThieryJP, SleemanJP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131–142. doi:10.1038/nrm183516493418
  • SchmalhoferO, BrabletzS, BrabletzT. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009;28(1–2):151–166. doi:10.1007/s10555-008-9179-y19153669
  • BerxG, RaspeE, ChristoforiG, ThieryJP, SleemanJP. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis. 2007;24(8):587–597. doi:10.1007/s10585-007-9114-617978854
  • KongD, LiY, WangZ, SarkarFH. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?Cancers. 2011;3(1):716–729. doi:10.3390/cancers3010071621643534
  • ChristoforiG, SembH. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 1999;24(2):73–76. doi:10.1016/S0968-0004(98)01343-710098402
  • HazanRB, PhillipsGR, QiaoRF, NortonL, AaronsonSA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000;148(4):779–790. doi:10.1083/jcb.148.4.77910684258
  • EgerA, AignerK, SondereggerS, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005;24(14):2375–2385. doi:10.1038/sj.onc.120842915674322
  • ComijnJ, BerxG, VermassenP, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7(6):1267–1278. doi:10.1016/S1097-2765(01)00260-X11430829
  • LiuH, MuD, LinT, LiQ. A simple method for the screening and measurement of phenols in Dendrobium chrysotoxum by a miniature mass detector using a matrix solid-phase dispersion method. J Anal Methods Chem. 2019;2019:6737632. doi:10.1155/2019/673763230809414
  • GongYQ, FanY, WuDZ, YangH, HuZB, WangZT. In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer. 2004;40(10):1554–1565. doi:10.1016/j.ejca.2004.01.04115196540
  • SunJ, FuX, WangY, et al. Erianin inhibits the proliferation of T47D cells by inhibiting cell cycles, inducing apoptosis and suppressing migration. Am J Transl Res. 2016;8(7):3077–3086.27508028
  • LiYM, WangHY, LiuGQ. Erianin induces apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin. 2001;22(11):1018–1022.11749794
  • WangH, ZhangT, SunW, et al. Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 2016;7(6):e2247. doi:10.1038/cddis.2016.13827253411
  • PettitGR, SinghSB, NivenML, HamelE, SchmidtJM. Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum. J Nat Prod. 1987;50(1):119–131. doi:10.1021/np50049a0163598594
  • PettitGR, SinghSB, BoydMR, et al. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a). J Med Chem. 1995;38(10):1666–1672. doi:10.1021/jm00010a0117752190
  • SimoniD, RomagnoliR, BaruchelloR, et al. Novel combretastatin analogues endowed with antitumor activity. J Med Chem. 2006;49(11):3143–3152. doi:10.1021/jm051073216722633
  • FosterPA, NewmanSP, LeeseMP, et al. A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer. Anticancer Res. 2008;28(2A):577–581.18506995
  • RaobaikadyB, ReedMJ, LeeseMP, PotterBV, PurohitA. Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates. Int J Cancer. 2005;117(1):150–159. doi:10.1002/ijc.2106615880363
  • VisagieMH, BirkholtzLM, JoubertAM. A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell lines. Cell Biosci. 2015;5:19. doi:10.1186/s13578-015-0010-525908963
  • PurohitA, HejazHA, WaldenL, et al. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int J Cancer. 2000;85(4):584–589. doi:10.1002/(SICI)1097-0215(20000215)85:4<584::AID-IJC22>3.0.CO;2-Q10699934
  • PadmanabanV, KrolI, SuhailY, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573(7774):439–444. doi:10.1038/s41586-019-1526-331485072
  • BuckleyCD, TanJ, AndersonKL, et al. Cell adhesion. The minimal cadherin-catenin complex binds to actin filaments under force. Science. 2014;346(6209):1254211. doi:10.1126/science.125421125359979
  • DemaliKA. Vinculin–a dynamic regulator of cell adhesion. Trends Biochem Sci. 2004;29(11):565–567. doi:10.1016/j.tibs.2004.09.00115501673
  • ChakrabartiR, HwangJ, Andres BlancoM, et al. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat Cell Biol. 2012;14(11):1212–1222. doi:10.1038/ncb260723086238